Artica TherapeuticsListed
No domain yetbiotech_life_sciences
Artica Therapeutics is dedicated to developing novel therapies for patients suffering from severe autoimmune and inflammatory disorders, leveraging covalent chemistry to create or…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Artica Therapeutics is dedicated to developing novel therapies for patients suffering from severe autoimmune and inflammatory disorders, leveraging covalent chemistry to create or…
Avidicure is pioneering an entirely new triple agonistic antibody modality, 'Actibody', designed to safely deliver targeted and potent monotherapy for patients, with broad applica…
Azafaros is a clinical-stage company focused on developing therapies for severe rare metabolic disorders, particularly lysosomal storage disorders. Their lead program, nizubaglust…
Brandaris Therapeutics is a biotechnology company focused on translational medicine, developing innovative therapeutic solutions.
Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases. Leveraging decades of drug develop…
CatalYm is pioneering the neutralization of GDF-15 to overcome cancer therapy resistance, developing safe and efficacious immune therapies for solid tumors, particularly focusing…
Citryll is a biotech company developing innovative therapies for immune-mediated inflammatory diseases by targeting Extracellular Traps. It raised EUR 85 million in Series B fundi…
Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for complement-mediated diseases, focusing initially on geographic atrophy, an adva…
Confo Therapeutics is a clinical-stage biotech company focused on accelerating novel medicines for metabolic and endocrine diseases using its proprietary GPCR-targeting technology.
Dunad Therapeutics combines proprietary, tunable covalent chemistry with a deep understanding of disease biology to discover and develop transformational medicines that selectivel…
Epsilogen is a clinical-stage company pioneering radically new antibody therapeutics for oncology, focusing on the development of immunoglobulin IgE, IgA, and IgG-based therapeuti…
Fibrocor Therapeutics is a Canadian biotech firm focused on developing treatments for kidney diseases, particularly Alport Syndrome, using innovative fibrosis-targeting therapies.
FundaMental Pharma is a preclinical, seed stage biopharmaceutical company dedicated to removing barriers in treatment-resistant depression. They are developing novel, dual-acting…
Genase Therapeutics develops GTX-196, a small molecule inhibitor targeting the DHODH enzyme for cancer treatment, aiming to exploit metabolic vulnerabilities in oncogene addicted…
Kivu Bioscience is focused on rapidly advancing next-generation transformative assets, particularly in the development of antibody-drug conjugates (ADCs) aimed at conquering cance…
NorthSea Therapeutics B.V. is a late-stage clinical biotechnology company developing novel and innovative strategies for the treatment of metabolic, cholestatic and fibrotic disea…
Phlox Pharma has been working since 2017 with a focus on providing efficient and effective healthcare support and novel products to address the challenges faced by the society. Ph…
River BioMedics develops novel, disease modifying small molecule therapies for cardiac diseases directly targeting the heart. By using unique human cardiac in vitro models for tar…
RougeTx develops small molecule drugs to treat microvascular bleeding diseases, starting in Hereditary Hemorrhagic Telangiectasia.
Scenic Biotech is pioneering modifier therapy, a novel approach to treating genetic disorders by targeting genetic modifiers—genes that naturally suppress or counteract the effect…
Stant is a recognized world leader in the design and manufacturing of vapor management systems, fuel delivery systems, thermal management systems and engineering services. With ov…
Tanai Therapeutics, based in Belgium, is developing a differentiated small molecule approach for obesity and cardiometabolic disease by targeting energy expenditure pathways. The…
Tessellate Bio is a biotechnology company focusing on novel synthetic lethality approaches beyond Homologous Recombination Deficiency (HRD). We are discovering and developing new…
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
VarmX is focused on developing VMX-C001, a breakthrough universal bypassing agent aimed at restoring blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa…
VectorY is pioneering vectorized antibody therapies to reverse the course of neurodegenerative disease, with a strong pipeline of potentially disease-modifying treatments for ALS,…
XS Innovations is developing breakthrough technology to control blood flow in hemodialysis patients, specifically through their patented Dynamic AVF device that opens and closes t…
Acerta Pharma is a European R&D centre of the AstraZeneca Group, dedicated to the discovery and development of novel innovative medicines for the treatment of haematological malig…
Argenx is a biotechnology company focused on developing innovative immunology solutions, particularly through antibody engineering and clinical trials to treat severe autoimmune d…
Bioceros B.V. operates as a biopharmaceutical research and development contract organization, focusing on providing a range of technical and scientific expertise from discovery re…
Dezima Pharma develops novel compounds to treat cardiovascular disease related to dyslipidemia. The company is known for its best-in-class CETP inhibitor for treating cardiovascul…
Lanthio Consulting helps fast-growing companies scale customer operations through smart tools, tailored workflows, and strategic consulting, focusing on customer support, success,…
Mellon Medical has developed a patented innovation in surgical suturing technology, enabling single-handed suturing with their device called The Switch. This technology aims to im…
NewAmsterdam Pharma is a biopharmaceutical company focused on developing treatments for metabolic diseases, particularly cardiovascular disease. It investigates obicetrapib for lo…
NovioGendix is a Swiss molecular diagnostics company developing a non-invasive liquid biopsy test for prostate cancer.
Progentix Orthobiology B.V. develops a unique suite of osteoinductive material products for clinical application in bone regenerative surgery, utilizing surface structured ceramic…
Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia.
SurgVision develops solutions for fluorescence-guided surgical and interventional oncology, focusing on real-time imaging during surgery to improve tumor detection.
Synaffix BV is a biotech company that has established a proprietary, clinical-stage antibody-drug conjugate (ADC) technology platform that delivers best-in-class ADCs (safety and…
Mironid is a biopharmaceutical company developing novel small-molecule therapeutics for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney…
TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED’s unique biolo…
Phosphoenix is developing a novel neuroprosthetic approach to restore functional vision in people with profound blindness by directly stimulating the brain’s visual pathway. The c…